BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18591874)

  • 21. Development of Tizanidine HCl-Meloxicam loaded mucoadhesive buccal films: In-vitro and in-vivo evaluation.
    Zaman M; Hanif M; Shaheryar ZA
    PLoS One; 2018; 13(3):e0194410. PubMed ID: 29566073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different HPMC viscosity grades as coating agents for an oral time and/or site-controlled delivery system: an investigation into the mechanisms governing drug release.
    Zema L; Maroni A; Foppoli A; Palugan L; Sangalli ME; Gazzaniga A
    J Pharm Sci; 2007 Jun; 96(6):1527-36. PubMed ID: 17094127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved oral absorption of tacrolimus by a solid dispersion with hypromellose and sodium lauryl sulfate.
    Jung HJ; Ahn HI; Park JY; Ho MJ; Lee DR; Cho HR; Park JS; Choi YS; Kang MJ
    Int J Biol Macromol; 2016 Feb; 83():282-7. PubMed ID: 26642839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and characterization of metoprolol tartrate containing matrix type transdermal drug delivery system.
    Malipeddi VR; Awasthi R; Ghisleni DD; de Souza Braga M; Kikuchi IS; de Jesus Andreoli Pinto T; Dua K
    Drug Deliv Transl Res; 2017 Feb; 7(1):66-76. PubMed ID: 27677866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transdermal atenolol releasing system: an approach towards its development.
    Gupta SP; Jain SK
    J Drug Target; 2006 Nov; 14(9):607-13. PubMed ID: 17090396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the interaction between water and (hydroxypropyl)methylcellulose.
    Nokhodchi A; Ford JL; Rubinstein MH
    J Pharm Sci; 1997 May; 86(5):608-15. PubMed ID: 9145387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a HPMC-based controlled release formulation with hot melt extrusion (HME).
    Ma D; Djemai A; Gendron CM; Xi H; Smith M; Kogan J; Li L
    Drug Dev Ind Pharm; 2013 Jul; 39(7):1070-83. PubMed ID: 22803806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biointerfacial phenomena of amlodipine buccomucosal tablets of HPMC matrix system containing polyacrylate polymer/β-cyclodextrin: Correlation of swelling and drug delivery performance.
    Panda B; Subhadarsini R; Mallick S
    Expert Opin Drug Deliv; 2016; 13(5):633-43. PubMed ID: 26878690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of misoprostol stabilization in hydroxypropyl methylcellulose.
    Kararli TT; Catalano T; Needham TE; Finnegan PM
    Adv Exp Med Biol; 1991; 302():275-89. PubMed ID: 1746334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of pH and ionic strength of dissolution media on in-vitro release of two model drugs of different solubilities from HPMC matrices.
    Asare-Addo K; Conway BR; Larhrib H; Levina M; Rajabi-Siahboomi AR; Tetteh J; Boateng J; Nokhodchi A
    Colloids Surf B Biointerfaces; 2013 Nov; 111():384-91. PubMed ID: 23850747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microwave non-destructive testing technique for characterization of HPMC-PEG 3000 films.
    Wong TW; Deepak KG; Taib MN; Anuar NK
    Int J Pharm; 2007 Oct; 343(1-2):122-30. PubMed ID: 17597317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controlled release polymeric ocular delivery of acyclovir.
    Deshpande PB; Dandagi P; Udupa N; Gopal SV; Jain SS; Vasanth SG
    Pharm Dev Technol; 2010; 15(4):369-78. PubMed ID: 19772377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. STUDYING THE IMPACT OF FORMULATION AND PROCESSING PARAMETERS ON THE RELEASE CHARACTERISTICS FROM HYDROXYPROPYL METHYLCELLULOSE MATRIX TABLETS OF DICLOFENAC.
    Elzayat EM; Abdel-Rahman AA; Ahmed SM; Alanazi FK; Habib WA; Sakr A
    Acta Pol Pharm; 2016; 73(2):439-52. PubMed ID: 27180437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and In Vitro/In Vivo Evaluation of Ultra-Thin Mucoadhesive Buccal Film Containing Fluticasone Propionate.
    Ammar HO; Ghorab MM; Mahmoud AA; Shahin HI
    AAPS PharmSciTech; 2017 Jan; 18(1):93-103. PubMed ID: 26883262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imperatorin sustained-release tablets: In vitro and pharmacokinetic studies.
    Pan J; Lu W; Li C; Wang S; He L
    Arch Pharm Res; 2010 Aug; 33(8):1209-16. PubMed ID: 20803124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development, evaluation and pharmacokinetics of time-dependent ketorolac tromethamine tablets.
    Vemula SK; Veerareddy PR
    Expert Opin Drug Deliv; 2013 Jan; 10(1):33-45. PubMed ID: 23199134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydroxypropyl methylcellulose: Physicochemical properties and ocular drug delivery formulations.
    Tundisi LL; Mostaço GB; Carricondo PC; Petri DFS
    Eur J Pharm Sci; 2021 Apr; 159():105736. PubMed ID: 33516807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of novel bioadhesive buccal formulation of diltiazem: in vitro and in vivo characterization.
    Shayeda ; Gannu R; Palem CR; Rao YM
    PDA J Pharm Sci Technol; 2009; 63(5):401-8. PubMed ID: 20158046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Swelling of hydroxypropyl methylcellulose matrix tablets. 2. Mechanistic study of the influence of formulation variables on matrix performance and drug release.
    Gao P; Skoug JW; Nixon PR; Ju TR; Stemm NL; Sung KC
    J Pharm Sci; 1996 Jul; 85(7):732-40. PubMed ID: 8818998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.